معرفی
Jörg Cammenga is a Senior Lecturer at Lund University's Division of Molecular Medicine and Gene Therapy. He serves as a Consultant, Specialist Research Team Manager, and Principal Investigator for both StemTherapy (National Initiative on Stem Cells for Regenerative Therapy) and LUCC (Lund University Cancer Centre). His research focuses on myeloid neoplasms, hematopoietic stem cell biology, and germline genetic predispositions to blood cancers.
- Division of Molecular Medicine and Gene Therapy, Lund University
- StemTherapy National Initiative
- LUCC (Lund University Cancer Centre)
Research interests include:
- Germline genetic mutations in myeloid malignancies
- Hematopoietic stem cell functionality
- Monosomy 7 chromosomal abnormalities
- Immune-based therapies for acute myeloid leukemia
- Regenerative medicine applications
- Familial platelet disorders
Recent research trends show a focus on:
- Genetic investigation guidelines for myeloid neoplasms
- Radiation effects on stem cell resilience
- Clinical management of germline predispositions
- Molecular mechanisms in myelodysplastic syndromes
- Collaborative Nordic research initiatives
۰مقاله منتشرشده
